Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:FBIN
NYSE:FBINBuilding

How Softer Q4 Results and Fiberon’s Novus Push At Fortune Brands Innovations (FBIN) Has Changed Its Investment Story

Fortune Brands Innovations, Inc. has reported past fourth-quarter 2025 results showing sales of US$1,077.5 million and net income of US$76.4 million, both lower than the same period a year earlier, with diluted earnings per share from continuing operations easing to US$0.63 from US$0.84. Alongside this softer quarter, the company’s Fiberon unit is preparing to showcase its Novus fused decking technology, highlighting Fortune Brands’ push toward higher-end, sustainable and innovation-focused...
AIM:JHD
AIM:JHDBuilding

Undervalued Small Caps With Insider Buying In European Markets February 2026

In February 2026, European markets have shown resilience amidst global volatility, with the STOXX Europe 600 Index reaching a new high and key indices like Germany's DAX and France's CAC 40 posting gains. This positive sentiment is supported by stable economic indicators such as unchanged ECB rates and a slowdown in inflation, creating an environment where small-cap stocks with strong fundamentals may present attractive opportunities for investors seeking growth potential.
OM:IVSO
OM:IVSOAerospace & Defense

3 European Stocks Estimated To Be Up To 49.8% Below Intrinsic Value

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has supported investor sentiment, with major indices like Germany's DAX and France's CAC 40 posting gains. In this environment of cautious optimism and stable interest rates from the European Central Bank, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential market opportunities.
XTRA:DBAN
XTRA:DBANCapital Markets

European Growth Stocks With Strong Insider Ownership

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has bolstered investor sentiment, leading to gains across major indices like Germany's DAX and France's CAC 40. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.
HLSE:FODELIA
HLSE:FODELIAFood

European Penny Stocks: 3 Picks Below €200M Market Cap

The pan-European STOXX Europe 600 Index recently reached a new intraday high, reflecting optimism about the eurozone economy despite ongoing market volatility. For investors seeking opportunities beyond well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing prospects. Although the term "penny stocks" might seem outdated, these investments remain relevant as they can provide growth potential at lower price points when backed by strong financials and...
OB:AFK
OB:AFKIndustrials

Undiscovered Gems in Europe To Explore This February 2026

As European markets continue to show resilience with the STOXX Europe 600 Index hitting new highs, optimism about the eurozone economy is helping to counteract recent market volatility. This positive sentiment provides a fertile ground for exploring small-cap stocks that may not yet be on investors' radars but hold potential due to their unique positioning and growth prospects in a stabilizing economic environment.
ENXTPA:TTE
ENXTPA:TTEOil and Gas

3 European Dividend Stocks To Watch With Up To 5.2% Yield

As optimism about the eurozone economy underpins investor sentiment, the pan-European STOXX Europe 600 Index has reached new highs despite recent market volatility. In this environment, dividend stocks can offer a compelling opportunity for investors seeking steady income streams and potential resilience amidst fluctuating economic conditions.
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Has Ligand Pharmaceuticals (LGND) Run Too Far After Its 59% One-Year Share Price Surge?

If you are wondering whether Ligand Pharmaceuticals at around US$181.65 is still offering value or has already run too far, you are not alone. The stock has seen a 59.4% return over the past year and 154.1% over three years, even though the last week and month showed 5.2% and 3.8% declines and year to date it is down 4.5%. Recent coverage has focused on Ligand's role as a platform company in pharmaceuticals and biotech partnerships, with attention on how its portfolio of royalty streams and...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope’s New Data Lineage Tool Might Change The Case For Investing In Netskope (NTSK)

Netskope recently announced Netskope One Data Lineage, a new capability designed to give enterprises granular visibility into how data is created, moves, and is used across their environments to support AI governance, compliance, and security objectives. The launch of Data Lineage, which extends Netskope One with provenance tracking, insider risk insights, and persistent data-aware policy controls, underscores how data governance and AI safety are becoming central requirements for cloud...